ACRS Aclaris Therapeutics, Inc.

NASDAQ

$5.15

Aclaris Therapeutics, Inc. (ACRS) Earnings News

Earnings press releases, previews and reviews for Aclaris Therapeutics, Inc. (ACRS), newest first.

Thursday August 6, 2026 6:59 AM ET

Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Thursday May 7, 2026 6:59 AM ET

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update